IN HIV-INFECTED INDIVIDUALS WHO DESIRE COMBINATION ANTIVIRAL THERAPY, ZIDOVUDINE PLUS ZALCITABINE IS PREFERRED TO ZIDOVUDINE PLUS DIDANOSINE

被引:81
|
作者
CARR, A [1 ]
COOPER, DA [1 ]
机构
[1] UNIV NEW S WALES,NATL CTR HIV EPIDEMIOL,SYDNEY,NSW,AUSTRALIA
关键词
D O I
10.1002/rmv.1980040104
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:5 / 8
页数:4
相关论文
共 50 条
  • [1] IN HIV-INFECTED INDIVIDUALS WHO DESIRE COMBINATION ANTIVIRAL THERAPY, ZIDOVUDINE PLUS DIDANOSINE IS PREFERRED TO ZIDOVUDINE PLUS ZALCITABINE
    MONTANER, JSG
    WAINBERG, MA
    OSHAUGHNESSY, MV
    [J]. REVIEWS IN MEDICAL VIROLOGY, 1994, 4 (01) : 9 - 12
  • [2] Delta: A randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
    Aber, V
    Aboulker, JP
    Babiker, AG
    Bragman, K
    Breckenridge, AM
    Carbon, C
    Charreau, I
    Chene, G
    Collis, P
    Cooper, D
    Darbyshire, JH
    Dormont, J
    Fiddian, P
    Flepp, M
    Gazzard, B
    Goebel, FD
    Hooker, M
    Lange, J
    Luthy, R
    Peto, TEA
    Reiss, P
    Seligmann, M
    Stone, AB
    Thomis, J
    Vella, S
    Walckenaer, G
    Warrell, D
    Weller, IVD
    Wilber, R
    Yeni, P
    Yeo, J
    Withnall, R
    [J]. LANCET, 1996, 348 (9023): : 283 - 291
  • [3] Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine
    Albrecht, MA
    Hughes, MD
    Liou, SH
    Katzenstein, DA
    Murphy, R
    Balfour, HH
    Para, MF
    Valdez, H
    Hammer, SM
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (14) : 1337 - 1344
  • [4] Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection
    Bartlett, JA
    Benoit, SL
    Johnson, VA
    Quinn, JB
    Sepulveda, GE
    Ehmann, WC
    Tsoukas, C
    Fallon, MA
    Self, PL
    Rubin, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (03) : 161 - +
  • [5] Delta: A randomised double-blind controlled trial comparing combination of zidovudine plus didanoside or zalcitabine with zidovudine alone in HIV-infected individuals (vol 348, pg 283, 1996)
    Davidson, F
    Peddie, H
    WansboroughJones, M
    Evans, M
    McDermott, S
    Walker, G
    VAnderMolen, B
    Donaldson, O
    [J]. LANCET, 1996, 348 (9030): : 834 - 834
  • [6] Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy
    Schooley, RT
    RamirezRonda, C
    Lange, JMA
    Cooper, DA
    Lavelle, J
    Lefkowitz, L
    Moore, M
    Larder, BA
    StClair, M
    Mulder, JW
    McKinnis, R
    Pennington, KN
    Harrigan, PR
    Kinghorn, I
    Steel, H
    Rooney, JF
    Ray, MG
    Kuritzkes, D
    RiveraVasquez, C
    Santana, J
    vanLeeuwen, R
    Boucher, C
    Reiss, P
    Veenstra, J
    Keet, R
    Pierce, P
    Haas, D
    Barnes, B
    Loewenthal, M
    DArcyEvans, C
    Kemp, S
    Kohli, A
    Myers, R
    Yeo, J
    Emery, S
    Romero, C
    Andrews, J
    Hanson, C
    Shortino, D
    Pattishall, K
    Barry, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06): : 1354 - 1366
  • [7] Zidovudine plus didanosine in the treatment of HIV asymptomatic patients previously treated with zidovudine
    Lopez-Martinez, C
    Jeannette-Guarner
    Magis-Rodriguez, C
    Uribe-Zuniga, P
    del Rio-Chiriboga, C
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1998, 50 (04): : 335 - 339
  • [8] HIV-1 resistance mutations and plasma RNA during zidovudine plus zalcitabine combination therapy
    Sylvester, A
    Caliendo, A
    An, D
    Savara, A
    Byington, R
    Strick, D
    Lillaney, R
    Sutton, L
    Sepkowitz, K
    Fischl, M
    Simon, G
    Lalezari, J
    Mitsuyasu, R
    DAquila, R
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 47 - 47
  • [9] Population pharmacokinetics of nevirapine, zidovudine and didanosine after combination therapy in HIV-infected patients.
    Zhou, XJ
    Sheiner, LB
    D'Aquila, RT
    Hughes, MD
    Hirsch, MS
    Fischl, MA
    Johnson, VA
    Myers, M
    Sommadossi, JP
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 182 - 182
  • [10] Randomised, multicentre phase III study of saquinavir plus zidovudine plus zalcitabine in previously untreated or minimally pretreated HIV-infected patients
    Stellbrink, HJ
    Hawkins, DA
    Clumeck, N
    Cooper, DA
    Myers, R
    Delfraissy, JF
    Gill, MJ
    Ramirez-Ronda, C
    Vella, S
    Salgo, M
    Bragman, K
    [J]. CLINICAL DRUG INVESTIGATION, 2000, 20 (05) : 295 - 307